|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Gain from settlement of account payable | |||||
| Share-based compensation expense | |||||
| Gain on disposal of discontinued operations | |||||
| Depreciation and amortization | |||||
| Impairment loss | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses | |||||
| Other current assets | |||||
| Operating lease assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued research and development costs | |||||
| Accrued expenses and other current liabilities | |||||
| Net cash used in operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||
| Net proceeds from disposal of discontinued operations | |||||
| Net cash provided by investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||
| Proceeds from ATM | |||||
| Proceeds from private placement | |||||
| Proceeds from exercises of stock options and ESPP | |||||
| Issuance costs paid for private placement | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Supplemental Cash Flow Information | |||||
| Cash and cash equivalents | |||||
| Non-cash gain on disposal of discontinued operations | |||||
Loading...